XLO · Xilio Therapeutics, Inc. · Proposed Sales
Market Cap
$51.64M
Shares
5.78M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1840233
CUSIP
98422T209
13F (30d)
13 filings
13 filers
Visit website
Investor relations